Possible involvement of p38 MAP kinase in prostaglandin E1-induced ALP activity in osteoblast-like cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 5, 2004, Pages 469-474

  Kakita, Ayako ^a   Suzuki, Atsushi ^b   Ono, Yasunaga ^b   Miura, Yoshitaka ^a   Itoh, Mitsuyasu ^b   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alkaline phosphatase; Osteoblasts; p38 MAP kinase; Prostaglandin E1

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKALINE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; WESTERN BLOTTING;

LATEOLABRAX JAPONICUS;

EID: 1842633468     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.09.003     Document Type: Article

References (28)

1. H. Kawaguchi, C.C. Pilbeam, J.R. Harrison, L.G. Raisz, The role of prostaglandins in the regulation of bone metabolism, Clin. Orthop. 313 (1995) 36-46.
2. 1 in infants with cyanotic congenital heart disease, J. Pediatr. 97 (1980) 834-836.
3. S.C. Marks Jr., S. Miller, Local infusion of prostaglandin-E1 stimulates mandibular bone formation in vivo, J. Oral. Pathol. 17 (1988) 500-505.
4. O.M. Faye-Peterson, W.H. Johnson Jr., W.A. Carlo, G.L. Hedlund, A.D. Pacifico, H.C. Blair, Prostaglandin E1-induced hyperostosis: clinicopathologic correlations and possible pathogenetic mechanisms, Pediatr. Pathol. Lab. Med. 16 (1996) 489-507.
5. 2, Endocrinology 130 (1992) 443-448.
6. R.S. Yang, W.M. Fu, S.M. Wang, K.S. Lu, T.K. Liu, S.Y. Lin-Shiau, Morphological changes induced by prostaglandin E in cultured rat osteoblasts, Bone 22 (1998) 629-636.
7. 2α stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro, Endocrinology 121 (1987) 1966-1973.
8. 1-induced alkaline phosphatase activity in osteoblast-like cells: regulation at a point downstream from protein kinase a, Prostagl. Leukot. Essent. Fatty Acids 55 (1996) 357-361.
9. 1 stimulates interleukin-6 secretion via protein kinase A in osteoblast-like cells, Cell Signal 9 (1997) 105-108.
10. S. Harada, J.A. Nagy, K.A. Sullivan, K.A. Thomas, N. Endo, G.A. Rodan, S.B. Rodan, Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts, J. Clin. Invest. 93 (1994) 2490-2496.
11. M. Suda, K. Tanaka, T. Natui, T. Usui, I. Tanaka, M. Fukushima, C. Shigeno, J. Konishi, S. Narumiya, A. Ichikawa, K. Nakao, Prostaglandin E receptor subtypes in mouse osteoblastic cell line, Endocrinology 137 (1996) 1698-1705.
12. G. Pearson, F. Robinson, T. Beers Gibson, B.E. Xu, M. Karandikar, K. Berman, M.H. Cobb, Mitogen-activated protein (MAP) kinase pathway: regulation physiological functions, Endocrine Rev. 22 (2001) 153-183.
13. A. Suzuki, G. Palmer, J.P. Bonjour, J. Caverzasio, Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells, J. Bone Miner. Res. 15 (2000) 95-102.
14. X. Zhen, J.P. Bonjour, J. Carverzasio, Platelet-derived growth factor stimulates sodium-dependent Pi transport in osteoblastic cells via phospholipase Cγ and phosphatidylinositol 3′-kinase, J. Bone Miner. Res. 12 (1997) 36-44.
15. J. Caverzasio, G. Palmer, A. Suzuki, J.P. Bonjor, Evidence for the involvement of two pathway in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells, J. Bone Miner. Res. 15 (2000) 1697-1706.
16. Y. Takeuthi, M. Suzawa, T. Kikuchi, E. Nishida, T. Fujita, T. Matsumoto, Differentiation and transforming growth factor-beta receptor down-regulation by collagen-α2β1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells, J. Biol. Chem. 272 (1997) 29309-29316.
17. H. Endoh, H. Sasaki, K. Maruyama, I. Waga, T. Shimizu, S. Kato, H. Kawashima, Rapid activation of MAP kinase by estrogen in the bone cell line, Biochem. Biophys. Res. Commun. 235 (1997) 264-269.
18. R. Nishimura, K. Moriyama, K. Yasukawa, G.R. Mundy, T. Yoneda, Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways MG-63 human osteoblastic cells, J. Bone Miner. Res. 13 (1998) 777-785.
19. N. Matsuda, N. Morita, K. Matsuda, M. Watanabe, Proliferation and differentiation of human osteoblastic cells associated with differential activation of MAP kinases in response to epidermal growth factor hypoxia and mechanical stress in vitro, Biochem. Biophys. Res. Commun. 249 (1998) 350-354.
20. A. Suzuki, J. Guicheux, G. Palmer, Y. Miura, Y. Oiso, J.P. Bonjour, J. Caverzasio, Evidences for p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation, Bone 30 (2002) 91-98.
21. A. Suzuki, G. Palmer, J.P. Bonjour, J. Caverzasio, Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells, Endocrinology 140 (1999) 3177-3182.
22. A. Suzuki, G. Palmer, J.P. Bonjour, J. Caverzasio, Cathecolamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells, Bone 23 (1998) 197-203.
23. O.K. Lowry, N.R. Robert, M.L. Wu, M.S. Hixson, E.J. Crawford, The quantitative histochemistry of brain. II. Enzyme measurements, J. Biol. Chem. 207 (1954) 19-37.
24. A. Cuenda, J. Rouse, Y.N. Doza, R. Meier, P. Choen, T.F. Gallagher, P.R. Young, J.C. Lee, SB203580 is a specific inhibitor of MAP kinase homologue which is stimulated by cellular stresses and interleukin-1, FEBS Lett. 364 (1995) 233-246.
25. T. Chijiwa, A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, H. Hidaka, Inhibition of forskolin-induced neunte outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5- isoquinolinesufonamide (H-89), of PC12D pheochromocytoma cells, J. Biol. Chem. 265 (1990) 5267-5272.
26. W.A. Peck, S.J. Brige Jr, S.A. Fedak, Bone cells: biochemical and biological studies after enzymatic isolation, Science 146 (1964) 1476-1477.
27. G.S. Stein, J.B. Lian, T.A. Owen, Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation, FASEB J. 4 (1990) 3111-3123.
28. G.L. Johnson, R. Lapadat, Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases, Science 298 (2002) 911-912.